InsidersTradesSigma
Follow the Beijing Biostar Pharmaceuticals Co., Ltd. - B stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Beijing Biostar Pharmaceuticals Co., Ltd. - B has recorded 2 reports. Market capitalisation: €1.3bn. The latest transaction was reported on 8 May 2026 (Purchase). Among the most active insiders: Tang Li. The full history is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
n/a
Sell Volume
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,397 of 29,063 companies
35.7
score / 100
Value16
Quality56
FCF yld-11%
Earn yld-9.4%
EV/EBITDA·
ROE-15%
Gross mgn92%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 May 2026
Declarations2 total
57,830,299 sharesShareXHKGHKEX:DA20260508E00311
2 of 2 declarations
Acerca de Beijing Biostar Pharmaceuticals Co., Ltd. - B
Beijing Biostar Pharmaceuticals Co., Ltd. es una empresa centrada en el desarrollo y la fabricación de productos farmacéuticos. Cotiza en la Bolsa de Hong Kong bajo el símbolo B.